Search Results

Deals

Selvita completes acquisition of PozLab and significantly expands its drug development capabilities

Selvita S.A. announced completion of a strategic transaction in which it has acquired 100% of shares in PozLab.

May 7, 2024

·

2 min read

Selvita launches biologic drug discovery and development services

Selvita S.A. announced a strategic initiative to significantly expand its services portfolio and enter the field of biologic drug discovery and development, by adding comprehensive therapeutic antibody discovery and development capabilities to its portfolio.

March 18, 2024

·

4 min read

The University of Oxford and Selvita Collaborate to Advance Potential Therapeutics for Parkinson’s Disease

The University of Oxford and Selvita, one of the largest contract research organizations in Europe, announced an integrated drug discovery collaboration in the area of Parkinson’s disease.

June 5, 2023

·

4 min read

Business

Selvita Q1 2023 financial results exceed initial estimates, the Company is preparing for further dynamic growth

Selvita S.A., one of the largest contract research organization companies in Europe, has published a financial report for Q1 2023*.

May 31, 2023

·

6 min read

Business

Selvita with record results in 2022, builds a base for further dynamic growth in upcoming periods

Selvita S.A. one of the largest CRO companies in Europe has published a full-year report for 2022.

March 30, 2023

·

8 min read

Business

Selvita Group reports strong business performance for Q3 YTD 2022

Selvita S.A., one of the largest contract research organizations in Europe, reported its financial results for Q3 2022. The Group continues its dynamic growth, exceeding the assumptions of the ambitious development strategy for 2022-2025 presented in March this year.

November 10, 2022

·

6 min read

Business

Immagene and Selvita Announce Integrated Drug Discovery Cooperation

Immagene and Selvita announce their cooperation on an integrated drug discovery project.

February 7, 2022

·

2 min read

Business

Selvita Group continues its dynamic growth in the first quarter of 2022

Selvita S.A., one of the largest preclinical contract research organizations in Europe, continues its development in all business segments in the first quarter of 2022.

May 31, 2022

·

5 min read

Business

Selvita exceeds its development strategy assumptions, estimates a 46%** increase in revenues in Q2 2022 and maintains high profitability

Selvita S.A., one of the largest contract research organizations in Europe, reported its preliminary financial results for Q2 and H1 2022*.

September 6, 2022

·

7 min read

Selvita sums up 2021 and announces Development Strategy for 2022-2025

Selvita S.A. one of the largest preclinical contract research organizations in Europe, continues its dynamic development in Poland and abroad.

March 31, 2022

·

10 min read